PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $709,000 | -0.6% | 11,851 | 0.0% | 0.01% | -10.0% |
| Q3 2020 | $713,000 | -79.6% | 11,851 | -82.2% | 0.01% | -79.6% |
| Q2 2020 | $3,496,000 | +44.6% | 66,613 | -7.6% | 0.05% | +28.9% |
| Q1 2020 | $2,418,000 | -22.3% | 72,113 | +5.7% | 0.04% | +22.6% |
| Q4 2019 | $3,110,000 | +18.0% | 68,213 | -1.4% | 0.03% | +6.9% |
| Q3 2019 | $2,635,000 | -12.5% | 69,213 | 0.0% | 0.03% | -9.4% |
| Q2 2019 | $3,011,000 | +19.9% | 69,213 | +4.9% | 0.03% | +14.3% |
| Q1 2019 | $2,511,000 | +35771.4% | 65,963 | +43584.1% | 0.03% | – |
| Q4 2018 | $7,000 | -95.4% | 151 | -95.4% | 0.00% | -100.0% |
| Q4 2017 | $151,000 | +21.8% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $124,000 | -21.0% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $157,000 | +15600.0% | 3,300 | +82400.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |